Ivermectin Glenmark

Ivermectin, the active ingredient in Ivermectin Glenmark, is an anthelmintic presented as an oral dosage form for systemic use. It is employed to treat a range of parasitic infections in both adult and pediatric patients, targeting nematodes and ectoparasites.

GNH USA supplies Ivermectin Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing regulatory support for global distribution.

Ivermectin is an anthelmintic that acts against a variety of helminthic and ectoparasitic diseases.

- Onchocerciasis (river blindness): reduces microfilarial load and prevents disease progression. - Strongyloidiasis: eradicates intestinal Strongyloides stercoralis infection. - Scabies: eliminates Sarcoptes scabiei mites, relieving skin infestation. - Lymphatic filariasis (in combination therapy): contributes to microfilariae clearance when used with albendazole. - Other helminth infections: treats various nematode infections such as ascariasis and hookworm.